OncoZenge: Delayed payment from investment agreement - Redeye

Redeye leaves a comment following OncoZenge’s announcement regarding the delayed payment of tranche 3 from the investment agreement with Yangtian. We believe that this introduces short-term financing uncertainty, but does not, in our view, alter the underlying strategic case.

Länk till analysen i sin helhet: https://www.redeye.se/research/1145775/oncozenge-delayed-payment-from-investment-agreement?utm_source=finwire&utm_medium=RSS